Author

Ana Christina Garrido-Castro

Dana-Farber Cancer InstituteORCID 0000-0002-5989-6636Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:differential expression· 1 Approach:experimental assay· 1 Research Focus:host-pathogen & immune response· 1 Organism:human· 1 Approach:matrix factorization· 1 Organism:mouse· 1 Approach:statistical model· 1 Research Focus:variant calling· 1

Frequent Co-Authors

Alinés Lebrón-TorresiD· 1 shared Andrew D. CherniackiD· 1 shared Anne-Marie FeeneyiD· 1 shared Ayesha Mohammed-AbreuiD· 1 shared Beth A. OvermoyeriD· 1 shared Beth T. HarrisoniD· 1 shared Brittany BychkovskyiD· 1 shared Bruce Evan JohnsoniD· 1 shared

Activity by Year

2025-2025 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 36 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperGenomics

Alinés Lebrón-TorresORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Cancer BiologybioRxivPreprintSep 12, 2025

Platelet-Mediated Suppression of T Cell Function Drives Immune Evasion in Triple Negative Breast Cancer through the P-Selectin / PSGL-1 Pathway

Margaret R. Smith-Oliver, Deepa Gautam, Emily M. Clarke…·Elisabeth M. Battinelli

This paper identifies a platelet-mediated immune evasion mechanism in TNBC via the P-selectin/PSGL-1 pathway, showing that blocking P-selectin can restore T-cell function and improve ICI response.

DOI 10.1101/2025.09.12.675650

mouseexperimental assay

GenomicsClinical Cancer ResearchPeer-reviewedMay 16, 2025

Clinicogenomic characterization of inflammatory breast cancer

Nolan Priedigkeit, Beth T. Harrison, Robert E. Shue…·Filipa C. Lynce

This study analyzes genomic alterations in a large IBC cohort, finding high TP53 mutation frequency and NOTCH pathway enrichment, but no major genomic differences compared to non-IBC cases.

5 citations

humanwhole-exome sequencing